News

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful conclusion of negotiations with the pan ...
The first drug to treat infants sick with malaria is approved by Swiss authority
Swissmedic gave a green light Tuesday for the medicine from Basel-based pharmaceutical company Novartis for treatment of ...